Will expand patient access to breakthrough BPH treatment San Francisco, CA (UroToday.com) — Teleflex Incorporated announced that the company has received reimbursement approval from the Central Social Insurance Medical Council of Japan (Chuikyo) of its UroLift System for patients who require treatment for benign prostatic hyperplasia (BPH).
(UroToday.com) In a plenary session at the Society of Urologic Oncology Annual Meeting focused on early prostate cancer diagnosis and treatment, Dr. Neil Desai discussed the role of hypofractionation for patients treated with radiotherapy for unfavourable risk localized prostate cancer.
(UroToday.com) In a plenary session at the Society of Urologic Oncology Annual Meeting focused on early prostate cancer diagnosis and treatment, Dr. Behfar Edhaie spoke, in place of Dr. Sigrid Carlsson, about considerations for the use of active surveillance in patients with grade group 2 prostate cancer.
(UroToday.com) In a plenary session at the Society of Urologic Oncology Annual Meeting focused on early prostate cancer diagnosis and treatment, Dr. Jennifer Gordetsky discussed pathological variants of prostate cancer and their influence on treatment.
(UroToday.com) In a plenary session of the Society of Urologic Oncology Annual Meeting focused on transperineal prostate biopsy, Dr. Edward Schaeffer began the session by discussing strategies to mitigate infections among patients undergoing prostate biopsy.
(UroToday.com) In a plenary session at the Society of Urologic Oncology Annual Meeting focused on early prostate cancer diagnosis and treatment, Dr. Burcu Darst discussed the role of polygenic risk scores (PRS) to improve prostate-specific antigen (PSA)-based prostate cancer screening.
(UroToday.com) In a plenary session of the Society of Urologic Oncology Annual Meeting focused on transperineal prostate biopsy, Dr. Jonathan Shoag discussed whether a transperineal biopsy should become the standard of care for patients undergoing prostate biopsy.
(UroToday.com) In a plenary session of the Society of Urologic Oncology Annual Meeting focused on transperineal prostate biopsy, Dr. Timothy McClure discussed considerations regarding local and regional anesthesia for transperineal and transrectal prostate biopsy, with a focus on the anatomic and neuro-anatomy of the pelvis.
(UroToday.com) In a plenary session of the Society of Urologic Oncology Annual Meeting focused on transperineal prostate biopsy, Dr. Badar Munir Mian discussed current trials assessing the role of transperineal biopsy in prostate cancer.
© European Union, [2021] – Source: European Parliament On Thursday 9 December, the European Parliament’s Special Committee on Beating Cancer concluded its final votes on the report on how to strengthen the European Union (EU)’s role in the fight against cancer by means of the implementation of Europe’s Beating Cancer Plan (EU Cancer Plan). The […]
